CGEN
Compugen Ltd.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
2.62
▼ 0.03 (1.13%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
2.55
Prev close
2.65
Day high
2.77
Day low
2.61
Volume
443.59K
Market cap
$247.70M
P/E (TTM)
6.88
52W range
1.30 – 3.24
Insider net activity
Net shares
+106.50K
Net buying
Buy transactions
20
157.50K shares
Sell transactions
11
51.00K shares
Net transactions
+31
Buys less sells
Sell : buy shares
0.3 : 1
Mixed
Insider-held shares
1.99M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 29, 26 | ZWEIFACH SANFORD S Director |
STOCK | 7.50K | $0 | Direct |
| Jul 29, 26 | LEVINE ZURIT Officer |
STOCK | 18.00K | $0 | Direct |
| Jul 29, 26 | SILBERMAN DAVID Chief Financial Officer |
STOCK | 19.50K | $0 | Direct |
| Jul 29, 26 | HUKKELHOVEN MATHIAS PH.D. Director |
STOCK | 7.50K | $0 | Direct |
| Jul 29, 26 | HALEVY GILEAD Director |
STOCK | 7.50K | $0 | Direct |
| Jul 9, 26 | LEVINE ZURIT Officer |
CONVERSION | 1.88K | $1.55K | Direct |
| Jul 9, 26 | LEVINE ZURIT Officer |
SELL | 1.88K | $4.69K | Direct |
| Apr 24, 26 | LEVINE ZURIT Officer |
CONVERSION | 2.00K | $2.30K | Direct |
| Apr 24, 26 | OPHIR ERAN Chief Executive Officer |
CONVERSION | 5.00K | $4.15K | Direct |
| Apr 24, 26 | LEVINE ZURIT Officer |
SELL | 2.00K | $6.40K | Direct |
| Apr 24, 26 | OPHIR ERAN Chief Executive Officer |
SELL | 5.00K | $16.00K | Direct |
| Apr 14, 26 | LEVINE ZURIT Officer |
CONVERSION | 2.00K | $2.30K | Direct |
| Apr 14, 26 | OPHIR ERAN Chief Executive Officer |
CONVERSION | 5.00K | $4.15K | Direct |
| Apr 14, 26 | LEVINE ZURIT Officer |
SELL | 2.00K | $5.60K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
HALEVY GILEAD |
Director | 18.91K | Stock Award(Grant) |
HUKKELHOVEN MATHIAS PH.D. |
Director | 17.50K | Stock Award(Grant) |
LEVINE ZURIT |
Officer | 47.38K | Stock Award(Grant) |
OPHIR ERAN |
Chief Executive Officer | 11.38K | Conversion of Exercise of derivative security |
SILBERMAN DAVID |
Chief Financial Officer | 55.00K | Stock Award(Grant) |
ZWEIFACH SANFORD S |
Director | 20.18K | Stock Award(Grant) |
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.05
Call-heavy session
Put / call open interest
0.51
Positioning, not flow
Max pain
2.50
-4.4% from spot
ATM implied vol
84.4%
Nearest strike to spot
Skew (10% OTM)
-21.9%
Calls bid over puts
Call volume
65
Contracts, this expiry
Put volume
3
Contracts, this expiry
Heaviest call OI
2.50
1.22K contracts
Heaviest put OI
2.50
958 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+8.71%
+10.1%
1M
+11.97%
+8.2%
3M
+0.38%
-2.7%
6M
+50.57%
+39.5%
YTD
+71.24%
+59.0%
1Y
+81.94%
+61.9%
3Y
+151.92%
+77.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$247.70M
Enterprise value$125.43M
Revenue (TTM)$74.00M
Gross profit$64.30M
EBITDA$30.68M
Net income$35.19M
EPS (TTM)$0.38
Free cash flow$22.22M
Total cash$125.30M
Total debt$3.02M
Book value / share$0.94
Shares outstanding94.72M
Float92.67M
Short % of float2.97%
Dividend yield—
Beta (5Y)2.78
Short interest
Shares short
2.81M
Prior 2.80M
Change vs prior
+0.6%
Shorts adding
% of float
2.97%
Normal
% of shares out
2.97%
Against total outstanding
Days to cover
11.4
Crowded exit
Float
92.67M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Valuation & profitability ratios
Trailing P/E6.88
Forward P/E-7.13
PEG ratio1.29
Price / sales—
Price / book2.79
EV / revenue1.70
EV / EBITDA4.09
Gross margin86.89%
Operating margin-339.62%
Profit margin47.55%
Return on equity50.64%
Return on assets15.46%
Debt / equity3.41
Current ratio5.72
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $72.76M | $27.86M | $33.46M | $7.50M | +161.1% |
| Operating revenue | $72.76M | $27.86M | $33.46M | $7.50M | +161.1% |
| Cost of revenue | $9.25M | $7.93M | $2.00M | $975.00K | +16.7% |
| Gross profit | $63.51M | $19.93M | $31.45M | $6.53M | +218.6% |
| Research & development | $22.76M | $24.81M | $34.47M | $30.65M | -8.3% |
| Selling, general & admin | $9.43M | $10.02M | $9.97M | $11.25M | -5.8% |
| Total operating expense | $32.19M | $34.83M | $44.45M | $41.90M | -7.6% |
| Operating income | $31.33M | -$14.89M | -$12.99M | -$35.37M | +310.4% |
| Net interest income | $4.38M | $5.20M | $3.21M | $1.41M | -15.8% |
| Pre-tax income | $35.40M | -$9.71M | -$9.78M | -$33.64M | +464.6% |
| Tax provision | $54.00K | $4.52M | $8.97M | $58.00K | -98.8% |
| Net income | $35.34M | -$14.23M | -$18.75M | -$33.69M | +348.4% |
| Net income to common | $35.34M | -$14.23M | -$18.75M | -$33.69M | +348.4% |
| Basic EPS | 0.38 | -0.16 | -0.21 | -0.39 | +337.5% |
| Diluted EPS | 0.38 | -0.16 | -0.21 | -0.39 | +337.5% |
| EBIT | $31.33M | -$14.89M | -$12.99M | -$35.37M | +310.4% |
| EBITDA | $31.80M | -$14.40M | -$12.52M | -$34.89M | +320.8% |
| Basic shares | 93.43M | 89.53M | 87.63M | 86.56M | +4.4% |
| Diluted shares | 93.82M | 89.53M | 87.63M | 86.56M | +4.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $90.60M | $18.23M | $13.89M | $11.06M | — | +397.0% |
| Cash & short-term investments | $145.64M | $103.25M | $50.69M | $83.35M | — | +41.0% |
| Accounts receivable | — | $0 | $61.00M | $0 | $0 | — |
| Total current assets | $148.02M | $106.00M | $114.58M | $86.13M | — | +39.6% |
| Property, plant & equipment | $3.20M | $3.69M | $2.54M | $3.36M | — | -13.3% |
| Total assets | $156.57M | $115.00M | $121.33M | $94.18M | — | +36.2% |
| Total current liabilities | $22.57M | $20.16M | $26.27M | $11.92M | — | +12.0% |
| Total debt | $2.96M | $2.91M | $1.35M | $1.93M | — | +1.6% |
| Total liabilities | $53.84M | $60.08M | $55.77M | $16.50M | — | -10.4% |
| Retained earnings | -$453.42M | -$488.76M | -$474.53M | -$455.77M | — | +7.2% |
| Shareholder equity | $102.73M | $54.91M | $65.56M | $77.68M | — | +87.1% |
| Working capital | $125.45M | $85.84M | $88.31M | $74.21M | — | +46.2% |
| Net tangible assets | $102.73M | $54.91M | $65.56M | $77.68M | — | +87.1% |
| Shares issued | 94.55M | 89.54M | 89.24M | 86.62M | — | +5.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $35.34M | -$14.23M | -$18.75M | -$33.69M | +348.4% |
| Depreciation & amortisation | $475.00K | $486.00K | $476.00K | $482.00K | -2.3% |
| Stock-based compensation | $1.88M | $3.02M | $3.55M | $4.33M | -37.8% |
| Change in working capital | -$5.35M | $62.05M | -$20.71M | -$5.55M | -108.6% |
| Operating cash flow | $31.63M | $49.60M | -$35.89M | -$34.11M | -36.2% |
| Capital expenditure | -$306.00K | -$118.00K | -$172.00K | -$487.00K | -159.3% |
| Investing cash flow | $30.00M | -$46.25M | $35.51M | $37.06M | +164.9% |
| Financing cash flow | $10.60M | $554.00K | $3.08M | $353.00K | +1,814.1% |
| Free cash flow | $31.33M | $49.49M | -$36.06M | -$34.60M | -36.7% |
| End cash position | $90.60M | $18.23M | $14.26M | $11.42M | +397.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.60M | $2.18M | $67.33M | $1.89M | $1.26M | +19.6% |
| Operating revenue | $2.60M | $2.18M | $67.33M | $1.89M | $1.26M | +19.6% |
| Cost of revenue | $2.69M | $1.82M | $3.54M | $1.65M | $1.67M | +47.7% |
| Gross profit | -$92.00K | $352.00K | $63.80M | $241.00K | -$408.00K | -126.1% |
| Research & development | $6.31M | $6.94M | $5.54M | $5.80M | $5.64M | -9.1% |
| Selling, general & admin | $2.44M | $2.43M | $2.21M | $2.33M | $2.38M | +0.2% |
| Total operating expense | $8.74M | $9.37M | $7.75M | $8.13M | $8.02M | -6.7% |
| Operating income | -$8.84M | -$9.02M | $56.04M | -$7.89M | -$8.43M | +2.0% |
| Net interest income | $1.84M | $1.35M | $1.11M | $954.00K | $1.07M | +35.8% |
| Pre-tax income | -$7.00M | -$7.66M | $56.84M | -$6.94M | -$7.36M | +8.7% |
| Tax provision | $7.00K | $5.00K | $0 | $40.00K | -$17.00K | +40.0% |
| Net income | -$7.01M | -$7.67M | $56.84M | -$6.98M | -$7.34M | +8.6% |
| Net income to common | -$7.01M | -$7.67M | $56.84M | -$6.98M | -$7.34M | +8.6% |
| Basic EPS | -0.07 | -0.08 | 0.60 | -0.07 | -0.08 | +12.5% |
| Diluted EPS | -0.07 | -0.08 | 0.60 | -0.07 | -0.08 | +12.5% |
| EBIT | -$8.84M | -$9.02M | $56.04M | -$7.89M | -$8.43M | +2.0% |
| EBITDA | -$8.84M | -$9.02M | $56.04M | -$7.89M | -$8.43M | +2.0% |
| Basic shares | 94.64M | 94.56M | 94.30M | 93.54M | 93.53M | +0.1% |
| Diluted shares | 94.64M | 94.56M | 94.71M | 93.54M | 93.53M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $10.28M | $12.44M | $90.60M | $7.46M | $6.47M | — | -17.3% |
| Cash & short-term investments | $125.30M | $134.95M | $145.64M | $86.09M | $93.88M | — | -7.1% |
| Accounts receivable | $680.00K | — | — | — | — | $0 | — |
| Total current assets | $129.41M | $137.28M | $148.02M | $88.92M | $97.64M | — | -5.7% |
| Property, plant & equipment | $3.11M | $3.10M | $3.20M | $3.38M | $3.52M | — | +0.3% |
| Total assets | $138.37M | $145.86M | $156.57M | $97.84M | $106.53M | — | -5.1% |
| Total current liabilities | $22.63M | $22.04M | $22.57M | $20.28M | $20.58M | — | +2.7% |
| Total debt | $3.02M | $2.93M | $2.96M | $2.95M | $2.97M | — | +3.1% |
| Total liabilities | $49.63M | $50.51M | $53.84M | $54.02M | $56.27M | — | -1.7% |
| Retained earnings | -$468.09M | — | -$453.42M | — | — | -$488.76M | — |
| Shareholder equity | $88.73M | $95.35M | $102.73M | $43.83M | $50.26M | — | -6.9% |
| Working capital | $106.78M | $115.25M | $125.45M | $68.64M | $77.06M | — | -7.4% |
| Net tangible assets | $88.73M | $95.35M | $102.73M | $43.83M | $50.26M | — | -6.9% |
| Shares issued | 94.55M | 94.58M | 94.55M | 93.54M | 93.54M | — | -0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.09 | -0.07 | +17.7% |
| Mar 2026 | -0.08 | -0.08 | 0.0% |
| Dec 2025 | 0.14 | 0.60 | +339.0% |
| Sep 2025 | -0.09 | -0.07 | +22.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.09 | 3 | $975.00K | -48.4% |
| Next quarter | -0.09 | 3 | $3.48M | -94.8% |
| Current year | -0.33 | 3 | $9.24M | -87.3% |
| Next year | -0.37 | 3 | $7.75M | -16.1% |
Analyst targets & ownership
Mean target$4.60
High target$6.00
Low target$4.00
Implied upside75.57%
Analyst count5
ConsensusSTRONG BUY
Strong buy / Buy0 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders2.10%
Held by institutions15.20%
Institutions holding92
Price targets, consensus spread, insider and institutional ownership.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 21, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
| Apr 7, 26 | Lake Street | INITIATED | — | Buy |
| Jan 7, 26 | HC Wainwright & Co. | INITIATED | — | Buy |
| May 21, 24 | Truist Securities | MAINTAINED | Buy | Buy |
| Mar 8, 24 | Truist Securities | MAINTAINED | Buy | Buy |
| Dec 19, 23 | Stifel | MAINTAINED | Buy | Buy |
| Aug 23, 23 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 7, 23 | EF Hutton | MAINTAINED | Buy | Buy |
| Jun 6, 23 | EF Hutton | MAINTAINED | — | Buy |
| May 26, 23 | EF Hutton | MAINTAINED | Buy | Buy |
| May 24, 23 | EF Hutton | MAINTAINED | Buy | Buy |
| May 16, 23 | Oppenheimer | MAINTAINED | Outperform | Outperform |
Moving averages & technicals
SMA 10
2.45
+6.94% from price
SMA 20
2.39
+9.58% from price
SMA 50
2.29
+14.49% from price
SMA 100
2.45
+6.82% from price
SMA 200
2.12
+23.45% from price
EMA 12
2.46
+6.60% from price
EMA 26
2.40
+9.12% from price
EMA 50
2.37
+10.44% from price
RSI (14)
62.7
Neutral
MACD (12,26,9)
0.06
Hist 0.02
ATR (14)
0.12
4.47% of price
Realised vol 30D
52.3%
Annualised
Bollinger upper
2.59
20, 2σ
Bollinger lower
2.19
20, 2σ
50 / 200 cross
Golden
2.29 vs 2.12
Trend bias
Above 200
+23.45%
Risk profile
Beta vs SPY
1.67
More volatile than market
Correlation to SPY
0.31
Loosely linked
Realised vol 30D
52.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-36.8%
Peak to trough
Max drawdown 5Y
-92.6%
Peak to trough
ATR 14
0.12
4.47% of price
Beta (reported)
2.78
5Y monthly, from filing
SEC filings
Corporate Changes & Voting Matters
6-K · 2026-08-03
Corporate Changes & Voting Matters
6-K · 2026-05-18
Corporate Changes & Voting Matters
6-K · 2026-03-02
Corporate Changes & Voting Matters
6-K · 2026-02-12
Corporate Changes & Voting Matters
6-K · 2025-12-17
Corporate Changes & Voting Matters
6-K · 2025-11-10
Corporate Changes & Voting Matters
6-K · 2025-10-14
Corporate Changes & Voting Matters
6-K · 2025-09-17
Headlines
Are Medical Stocks Lagging Compugen (CGEN) This Year?
Zacks · 1d ago
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ...
GuruFocus.com · 17d ago
Compugen Ltd. Q2 2026 Earnings Call Summary
Moby · 18d ago
Compugen Q2 Earnings Call Highlights
MarketBeat · 19d ago
Compugen (CGEN) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 19d ago
Compugen: Q2 Earnings Snapshot
Associated Press · 20d ago
Compugen Reports Second Quarter 2026 Results
PR Newswire · 20d ago
Earnings To Watch: Compugen Ltd (CGEN) Reports Q2 2026 Result
GuruFocus.com · 22d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.